ADDITIONAL INFO

Vasoactive Intestinal Peptide (VIP) — Neuropeptide Research Compound

Vasoactive Intestinal Peptide (VIP) is a neuropeptide studied in laboratory research for its anti-inflammatory, immunomodulatory, and antifibrotic effects. Preclinical studies investigate its potential to influence fibrotic pathways, immune signaling, and tissue protection in models of neurodegeneration, pulmonary fibrosis, inflammatory bowel disease, and cardiac fibrosis. Research also explores VIP’s ability to protect the central nervous system and support cognitive function under experimental conditions.

For in‑vitro laboratory research only. Not a drug, food, cosmetic, or veterinary product. Not for human or animal administration.

Product Details

Compound Name: Vasoactive Intestinal Peptide (VIP)
Net Contents: 5-10 mg lyophilized powder per vial (batch-dependent) (3mL)
Form: Lyophilized (freeze-dried) powder
Purity: ≥98% (HPLC tested; Certificate of Analysis available)
Primary Targets: Fibrotic pathways, immune modulation, central nervous system signaling
Manufactured in: GMP-compliant facility
Intended Use: Laboratory research use only — not for human or veterinary use

Storage & Handling

• Store sealed at −20 °C, protected from light and moisture

• Allow container to reach room temperature before opening

• Prepare using appropriate sterile laboratory solvents or buffers

• Avoid repeated freeze–thaw after solution preparation

• Review SDS for hazards and safety guidance

Research Applications

VIP is commonly used in laboratory and preclinical studies to investigate:

• Anti-inflammatory mechanisms and immune modulation

• Fibrotic pathway regulation in cardiac, pulmonary, and intestinal models

• Neuroprotection and central nervous system support

• Cognitive function in models of neurodegenerative disease

• Tissue protection and repair in preclinical experimental systems